US Stock MarketDetailed Quotes

INO Inovio Pharmaceuticals

Watchlist
  • 5.6700
  • +0.0500+0.89%
Close Nov 6 16:00 ET
  • 5.7000
  • +0.0300+0.53%
Post 17:22 ET
147.22MMarket Cap-1118P/E (TTM)

Inovio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inovio Pharmaceuticals Q3 2024 Estimates Date

Currency：USDNov 14, 2024

Estimate YoY
Revenue
104.50K
-73.10%
EPS
-1.15
+26.28%
Analyst Rating
Buy

Oct 31, 2024

Inovio Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q4 -- / 121.200K --
Nov 14, 2024 2024/Q3 -- / 104.500K --
Aug 8, 2024 2024/Q2 100.760K / 121.500K --
May 13, 2024 2024/Q1 0.000 / 150.800K --
Mar 6, 2024 2023/Q4 102.650K / 344.120K --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 121.200K--
Nov 14, 20242024/Q3-- / 104.500K--
Aug 8, 20242024/Q2100.760K / 121.500K--
May 13, 20242024/Q10.000 / 150.800K--
Mar 6, 20242023/Q4102.650K / 344.120K--

Unlock Free Earnings Estimates

Inovio Pharmaceuticals Earnings Reports

  • Inovio Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 9 04:14

  • Inovio Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 14 04:05

  • Inovio Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 7 05:06

  • Inovio Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 10, 2023 05:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Mpox (monkeypox)
    Mpox (monkeypox)
    Intraday-1.18%